Moderna won’t enforce COVID-19 patents

Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Dems pressure Biden to share Moderna vaccine tech

14 October 2021 A group of 12 Democratic Party members, including Senator Elizabeth Warren, have co-signed a letter calling for the Biden administration to share Moderna’s vaccine technology.

Americas

Moderna’s COVID-19 and Zika patent applications to be investigated

8 September 2020 A US Department of Health and Human Services agency will investigate whether Moderna disclosed information on government funding in patent applications relating to its COVID-19 vaccine.

Americas

Moderna unsure of COVID-19 vaccine patent exclusivity

12 August 2020 US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Moderna won’t enforce COVID-19 patents

More on this story

Editor's picks

Editor's picks

More features